Qube Research & Technologies LTD Regenxbio Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Regenxbio Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 457,112 shares of RGNX stock, worth $5.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
457,112
Previous 392,795
16.37%
Holding current value
$5.28 Million
Previous $2.81 Million
33.62%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RGNX
# of Institutions
181Shares Held
45.2MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$99.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$55.2 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$50.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$39.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$21.3 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $500M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...